01

We are a venture builder

enabling innovation in the healthcare technology space.

About Us
02

We create startups

from promising R&D, transforming pioneering science into healthcare solutions.

About Us
03

We bridge the gap

between cutting-edge academic science and the successful commercialization of groundbreaking technologies.

About Us
04

We are Cube Labs

About Us

Our Focus Areas

We meticulously select cutting-edge technologies with strong commercial potential.

We do this, to meet global healthcare demands and strategically invest in their development to ensure their success.

Pharmaceuticals

Pharmaceuticals

BioTech

BioTech

Nutraceuticals

Nutraceuticals

R&D Tech / AI

R&D Tech / AI

MedTech

MedTech

Cube Labs at a glance

0

offices

0+M€

assets value

0+

universities in our network

0

startups

0

patents

0+

researchers in our network

Spearheading

democratization of healthcare

We aim to accelerate the democratization of the Life Science sector, making research, technologies, and tools more accessible to a wider audience.

This requires dismantling the barriers that restrict access to scientific information and fostering open innovation. By promoting the sharing of ideas and resources among institutions, companies, and individuals, we encourage new forms of collaboration and co-creation.

At Cube Labs, we are dedicated to driving meaningful change in healthcare, and we are excited about the future of innovation.

SUSTAINABILITY

REPORT

A document that reflects our ongoing commitment to social, environmental and economic sustainability and to the achievement of the Goals of the United Nations 2030 Agenda.



Achievements & Awards

Achievements & Awards

Cfi.co-2025_
motore_Italia_2025

Latest News

IP

ADAMAS BIOTECH (CUBE LABS) PRESENTA DOMANDA DI BREVETTO PER INNOVATIVA SOLUZIONE PER LA SALUTE INTESTINALE

Milano, 31 luglio 2025 – Adamas Biotech, startup controllata da Cube Labs che sfrutta le proprietà antinfiammatorie, antiossidanti e analgesiche degli estratti di tè verde…...
Financial

PERFEZIONATA SOTTOSCRIZIONE DI N° 475.000 AZIONI NELL’AMBITO DELL’AUMENTO DI CAPITALE PER UN CONTROVALORE DI EURO 1.045.000

Roma, 28 luglio 2025 – Cube Labs S.p.A. (“Cube Labs” o “Società”) – venture builder italiano nel settore delle tecnologie sanitarie quotato su Euronext Growth…...
IP

CUBE LABS: FIRMA DEL CONTRATTO PER LA CONCESSIONE IN LICENZA DELLA TECNOLOGIA SVILUPPATA DALL’IIT ALLA START-UP CHROMAPATCH

Roma, 17 luglio 2025 – Cube Labs S.p.A. (“Cube Labs” o “Società”) – venture builder italiano nel settore delle tecnologie sanitarie quotato su Euronext Growth…...